Search for: "Illumina, Inc. " Results 21 - 40 of 168
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Mar 2012, 12:23 pm by Robert Vrana
Earlier this week, a jury reached a decision in the longstanding dispute between LadaTech LLC and Illumina Inc, finding that Illumina's DNA sequencing products infringe LadaTech's genome technology patent. [read post]
4 Aug 2020, 2:15 pm by Rebecca Tapscott
On August 3, the United States Court of Appeals for the Federal Circuit (CAFC) denied a petition for rehearing en banc and issued a modified opinion, following a petition for rehearing filed by Ariosa in Illumina, Inc. v. [read post]
9 Feb 2018, 7:15 am by Steve Brachmann
A jury verdict awarded more than $26 million to a group of plaintiffs including San Diego, CA-based gene analysis firm Illumina, Inc. [read post]
8 Jan 2020, 3:00 am by John Jenkins
  Here’s the intro: On January 2, 2020, Illumina, Inc. [read post]
8 Aug 2016, 8:46 am by Daily Record Staff
Personal Genome Diagnostics Inc., a Baltimore-based provider of advanced cancer genome testing products and services, today announced an agreement with Illumina, Inc. to develop two in-vitro diagnostic test kits for use on Illumina’s sequencing instruments, including kits for the detection and characterization of tumor DNA using both tissue and plasma samples. [read post]
24 Jun 2013, 5:47 am
("Syntrix") filed a patent infringement action against Illumina, Inc. [read post]
16 Jul 2019, 1:54 am
Illumina and Sequenom have since joined forces in going after other players in the field. [read post]
14 Dec 2014, 10:00 pm by Courtenay C. Brinckerhoff
Less than a month after their case was argued at the Federal Circuit, Illumina Inc. and Sequenom Inc. have announced a deal to settle their patent infringement litigation. [read post]
9 Feb 2018, 7:15 am by Steve Brachmann
A jury verdict awarded more than $26 million to a group of plaintiffs including San Diego, CA-based gene analysis firm Illumina, Inc. [read post]
30 Aug 2021, 8:11 am by Cinthia Macie
Federal Trade Commission on Tuesday said it seeks to unwind life science company Illumina Inc’s $7.1 billion acquisition of Grail Inc, alleging it would harm innovation and boost prices. [read post]
23 May 2012, 5:25 am
The patents are directed to a method and an apparatus for conducting genetic testing using microarrays and are assigned to the defendant, Illumina, Inc. [read post]
25 Apr 2023, 8:33 am by Zak Gowen
  A U.S. appeals court said it will accelerate reviewing Illumina Inc’s challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test maker Grail LLC. [read post]